Angus C. Russell

Insider Reports History

Entity
Individual
Location
C/O Intermune, Inc., 3280 Bayshore Boulevard, Brisbane, CA
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Angus C. Russell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 51.5K $196K $3.80 May 1, 2024 Direct
TherapeuticsMD, Inc. Director Restricted Stock Units 5K $18.2K $3.64 Sep 29, 2022 Direct
Lineage Cell Therapeutics, Inc. Director Stock Option (Right to Buy) 75K Jul 1, 2024 Direct
Structure Therapeutics Inc. Director Share option (right to buy) 75K Aug 26, 2024 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23.5K May 1, 2024 Direct

Insider Reports Filed by Angus C. Russell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GPCR Structure Therapeutics Inc. Aug 26, 2024 1 $0 4 Aug 28, 2024 Director
GPCR Structure Therapeutics Inc. Aug 26, 2024 0 $0 3 Aug 28, 2024 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Director
RVNC Revance Therapeutics, Inc. May 1, 2024 2 $0 4 May 3, 2024 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 3, 2023 Director
RVNC Revance Therapeutics, Inc. May 3, 2023 2 $0 4 May 5, 2023 Director
TXMD TherapeuticsMD, Inc. Sep 29, 2022 1 $0 4 Oct 3, 2022 Director
TXMD TherapeuticsMD, Inc. Aug 18, 2022 2 $0 4 Aug 22, 2022 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
MNKPF Mallinckrodt plc Jun 16, 2022 0 $0 4 Jun 21, 2022 Director
RVNC Revance Therapeutics, Inc. May 4, 2022 1 $0 4/A May 13, 2022 Director
RVNC Revance Therapeutics, Inc. Dec 13, 2021 1 $101K 4 Dec 15, 2021 Director
TXMD TherapeuticsMD, Inc. Aug 10, 2021 2 $0 4 Aug 12, 2021 Director
TXMD TherapeuticsMD, Inc. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
LCTX Lineage Cell Therapeutics, Inc. Jul 1, 2021 1 $0 4 Jul 1, 2021 Director
LCTX Lineage Cell Therapeutics, Inc. Jun 29, 2021 3 $40.4K 4 Jun 30, 2021 Director
RVNC Revance Therapeutics, Inc. May 5, 2021 2 $0 4 May 7, 2021 Director